The global Immuno-Oncology Treatment market was valued at US$ 89.2 billion in 2024 and is projected to reach US$ 165.7 billion by 2030, at a CAGR of 10.9% during the forecast period 2024-2030.
Report Overview
This report provides a deep insight into the global Immuno-Oncology Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Immuno-Oncology Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Immuno-Oncology Treatment market in any manner.
Global Immuno-Oncology Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda
Market Segmentation (by Type)
Immune Checkpoint Inhibitors
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Market Segmentation (by Application)
Hospitals
Ambulatory Surgical Center
Others
Geographic Segmentation
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Immuno-Oncology Treatment
1.2 Key Market Segments
1.2.1 Immuno-Oncology Treatment Segment by Type
1.2.2 Immuno-Oncology Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Immuno-Oncology Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Immuno-Oncology Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Immuno-Oncology Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Immuno-Oncology Treatment Market Competitive Landscape
3.1 Global Immuno-Oncology Treatment Sales by Manufacturers (2019-2024)
3.2 Global Immuno-Oncology Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Immuno-Oncology Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Immuno-Oncology Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Immuno-Oncology Treatment Sales Sites, Area Served, Product Type
3.6 Immuno-Oncology Treatment Market Competitive Situation and Trends
3.6.1 Immuno-Oncology Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Immuno-Oncology Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Immuno-Oncology Treatment Industry Chain Analysis
4.1 Immuno-Oncology Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Immuno-Oncology Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Immuno-Oncology Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immuno-Oncology Treatment Sales Market Share by Type (2019-2024)
6.3 Global Immuno-Oncology Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Immuno-Oncology Treatment Price by Type (2019-2024)
7 Immuno-Oncology Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immuno-Oncology Treatment Market Sales by Application (2019-2024)
7.3 Global Immuno-Oncology Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Immuno-Oncology Treatment Sales Growth Rate by Application (2019-2024)
8 Immuno-Oncology Treatment Market Segmentation by Region
8.1 Global Immuno-Oncology Treatment Sales by Region
8.1.1 Global Immuno-Oncology Treatment Sales by Region
8.1.2 Global Immuno-Oncology Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Immuno-Oncology Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Immuno-Oncology Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Immuno-Oncology Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Immuno-Oncology Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Immuno-Oncology Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Amgen
9.1.1 Amgen Immuno-Oncology Treatment Basic Information
9.1.2 Amgen Immuno-Oncology Treatment Product Overview
9.1.3 Amgen Immuno-Oncology Treatment Product Market Performance
9.1.4 Amgen Business Overview
9.1.5 Amgen Immuno-Oncology Treatment SWOT Analysis
9.1.6 Amgen Recent Developments
9.2 AstraZeneca
9.2.1 AstraZeneca Immuno-Oncology Treatment Basic Information
9.2.2 AstraZeneca Immuno-Oncology Treatment Product Overview
9.2.3 AstraZeneca Immuno-Oncology Treatment Product Market Performance
9.2.4 AstraZeneca Business Overview
9.2.5 AstraZeneca Immuno-Oncology Treatment SWOT Analysis
9.2.6 AstraZeneca Recent Developments
9.3 Bristol-Myers Squibb
9.3.1 Bristol-Myers Squibb Immuno-Oncology Treatment Basic Information
9.3.2 Bristol-Myers Squibb Immuno-Oncology Treatment Product Overview
9.3.3 Bristol-Myers Squibb Immuno-Oncology Treatment Product Market Performance
9.3.4 Bristol-Myers Squibb Immuno-Oncology Treatment SWOT Analysis
9.3.5 Bristol-Myers Squibb Business Overview
9.3.6 Bristol-Myers Squibb Recent Developments
9.4 Eli-Lilly
9.4.1 Eli-Lilly Immuno-Oncology Treatment Basic Information
9.4.2 Eli-Lilly Immuno-Oncology Treatment Product Overview
9.4.3 Eli-Lilly Immuno-Oncology Treatment Product Market Performance
9.4.4 Eli-Lilly Business Overview
9.4.5 Eli-Lilly Recent Developments
9.5 Roche
9.5.1 Roche Immuno-Oncology Treatment Basic Information
9.5.2 Roche Immuno-Oncology Treatment Product Overview
9.5.3 Roche Immuno-Oncology Treatment Product Market Performance
9.5.4 Roche Business Overview
9.5.5 Roche Recent Developments
9.6 GlaxoSmithKline
9.6.1 GlaxoSmithKline Immuno-Oncology Treatment Basic Information
9.6.2 GlaxoSmithKline Immuno-Oncology Treatment Product Overview
9.6.3 GlaxoSmithKline Immuno-Oncology Treatment Product Market Performance
9.6.4 GlaxoSmithKline Business Overview
9.6.5 GlaxoSmithKline Recent Developments
9.7 Janssen Biotech
9.7.1 Janssen Biotech Immuno-Oncology Treatment Basic Information
9.7.2 Janssen Biotech Immuno-Oncology Treatment Product Overview
9.7.3 Janssen Biotech Immuno-Oncology Treatment Product Market Performance
9.7.4 Janssen Biotech Business Overview
9.7.5 Janssen Biotech Recent Developments
9.8 Merck
9.8.1 Merck Immuno-Oncology Treatment Basic Information
9.8.2 Merck Immuno-Oncology Treatment Product Overview
9.8.3 Merck Immuno-Oncology Treatment Product Market Performance
9.8.4 Merck Business Overview
9.8.5 Merck Recent Developments
9.9 Novartis
9.9.1 Novartis Immuno-Oncology Treatment Basic Information
9.9.2 Novartis Immuno-Oncology Treatment Product Overview
9.9.3 Novartis Immuno-Oncology Treatment Product Market Performance
9.9.4 Novartis Business Overview
9.9.5 Novartis Recent Developments
9.10 Pfizer
9.10.1 Pfizer Immuno-Oncology Treatment Basic Information
9.10.2 Pfizer Immuno-Oncology Treatment Product Overview
9.10.3 Pfizer Immuno-Oncology Treatment Product Market Performance
9.10.4 Pfizer Business Overview
9.10.5 Pfizer Recent Developments
9.11 Sanofi
9.11.1 Sanofi Immuno-Oncology Treatment Basic Information
9.11.2 Sanofi Immuno-Oncology Treatment Product Overview
9.11.3 Sanofi Immuno-Oncology Treatment Product Market Performance
9.11.4 Sanofi Business Overview
9.11.5 Sanofi Recent Developments
9.12 Spectrum Pharmaceuticals
9.12.1 Spectrum Pharmaceuticals Immuno-Oncology Treatment Basic Information
9.12.2 Spectrum Pharmaceuticals Immuno-Oncology Treatment Product Overview
9.12.3 Spectrum Pharmaceuticals Immuno-Oncology Treatment Product Market Performance
9.12.4 Spectrum Pharmaceuticals Business Overview
9.12.5 Spectrum Pharmaceuticals Recent Developments
9.13 Takeda
9.13.1 Takeda Immuno-Oncology Treatment Basic Information
9.13.2 Takeda Immuno-Oncology Treatment Product Overview
9.13.3 Takeda Immuno-Oncology Treatment Product Market Performance
9.13.4 Takeda Business Overview
9.13.5 Takeda Recent Developments
10 Immuno-Oncology Treatment Market Forecast by Region
10.1 Global Immuno-Oncology Treatment Market Size Forecast
10.2 Global Immuno-Oncology Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Immuno-Oncology Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Immuno-Oncology Treatment Market Size Forecast by Region
10.2.4 South America Immuno-Oncology Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Immuno-Oncology Treatment by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Immuno-Oncology Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Immuno-Oncology Treatment by Type (2025-2030)
11.1.2 Global Immuno-Oncology Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Immuno-Oncology Treatment by Type (2025-2030)
11.2 Global Immuno-Oncology Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Immuno-Oncology Treatment Sales (K Units) Forecast by Application
11.2.2 Global Immuno-Oncology Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Immuno-Oncology Treatment Market Size Comparison by Region (M USD)
Table 5. Global Immuno-Oncology Treatment Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Immuno-Oncology Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Immuno-Oncology Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Immuno-Oncology Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology Treatment as of 2022)
Table 10. Global Market Immuno-Oncology Treatment Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Immuno-Oncology Treatment Sales Sites and Area Served
Table 12. Manufacturers Immuno-Oncology Treatment Product Type
Table 13. Global Immuno-Oncology Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Immuno-Oncology Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Immuno-Oncology Treatment Market Challenges
Table 22. Global Immuno-Oncology Treatment Sales by Type (K Units)
Table 23. Global Immuno-Oncology Treatment Market Size by Type (M USD)
Table 24. Global Immuno-Oncology Treatment Sales (K Units) by Type (2019-2024)
Table 25. Global Immuno-Oncology Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Immuno-Oncology Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Immuno-Oncology Treatment Market Size Share by Type (2019-2024)
Table 28. Global Immuno-Oncology Treatment Price (USD/Unit) by Type (2019-2024)
Table 29. Global Immuno-Oncology Treatment Sales (K Units) by Application
Table 30. Global Immuno-Oncology Treatment Market Size by Application
Table 31. Global Immuno-Oncology Treatment Sales by Application (2019-2024) & (K Units)
Table 32. Global Immuno-Oncology Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Immuno-Oncology Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Immuno-Oncology Treatment Market Share by Application (2019-2024)
Table 35. Global Immuno-Oncology Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Immuno-Oncology Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Global Immuno-Oncology Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Immuno-Oncology Treatment Sales by Country (2019-2024) & (K Units)
Table 39. Europe Immuno-Oncology Treatment Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Immuno-Oncology Treatment Sales by Region (2019-2024) & (K Units)
Table 41. South America Immuno-Oncology Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Immuno-Oncology Treatment Sales by Region (2019-2024) & (K Units)
Table 43. Amgen Immuno-Oncology Treatment Basic Information
Table 44. Amgen Immuno-Oncology Treatment Product Overview
Table 45. Amgen Immuno-Oncology Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Amgen Business Overview
Table 47. Amgen Immuno-Oncology Treatment SWOT Analysis
Table 48. Amgen Recent Developments
Table 49. AstraZeneca Immuno-Oncology Treatment Basic Information
Table 50. AstraZeneca Immuno-Oncology Treatment Product Overview
Table 51. AstraZeneca Immuno-Oncology Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Immuno-Oncology Treatment SWOT Analysis
Table 54. AstraZeneca Recent Developments
Table 55. Bristol-Myers Squibb Immuno-Oncology Treatment Basic Information
Table 56. Bristol-Myers Squibb Immuno-Oncology Treatment Product Overview
Table 57. Bristol-Myers Squibb Immuno-Oncology Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Bristol-Myers Squibb Immuno-Oncology Treatment SWOT Analysis
Table 59. Bristol-Myers Squibb Business Overview
Table 60. Bristol-Myers Squibb Recent Developments
Table 61. Eli-Lilly Immuno-Oncology Treatment Basic Information
Table 62. Eli-Lilly Immuno-Oncology Treatment Product Overview
Table 63. Eli-Lilly Immuno-Oncology Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Eli-Lilly Business Overview
Table 65. Eli-Lilly Recent Developments
Table 66. Roche Immuno-Oncology Treatment Basic Information
Table 67. Roche Immuno-Oncology Treatment Product Overview
Table 68. Roche Immuno-Oncology Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Roche Business Overview
Table 70. Roche Recent Developments
Table 71. GlaxoSmithKline Immuno-Oncology Treatment Basic Information
Table 72. GlaxoSmithKline Immuno-Oncology Treatment Product Overview
Table 73. GlaxoSmithKline Immuno-Oncology Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. GlaxoSmithKline Business Overview
Table 75. GlaxoSmithKline Recent Developments
Table 76. Janssen Biotech Immuno-Oncology Treatment Basic Information
Table 77. Janssen Biotech Immuno-Oncology Treatment Product Overview
Table 78. Janssen Biotech Immuno-Oncology Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Janssen Biotech Business Overview
Table 80. Janssen Biotech Recent Developments
Table 81. Merck Immuno-Oncology Treatment Basic Information
Table 82. Merck Immuno-Oncology Treatment Product Overview
Table 83. Merck Immuno-Oncology Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Merck Business Overview
Table 85. Merck Recent Developments
Table 86. Novartis Immuno-Oncology Treatment Basic Information
Table 87. Novartis Immuno-Oncology Treatment Product Overview
Table 88. Novartis Immuno-Oncology Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Novartis Business Overview
Table 90. Novartis Recent Developments
Table 91. Pfizer Immuno-Oncology Treatment Basic Information
Table 92. Pfizer Immuno-Oncology Treatment Product Overview
Table 93. Pfizer Immuno-Oncology Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Pfizer Business Overview
Table 95. Pfizer Recent Developments
Table 96. Sanofi Immuno-Oncology Treatment Basic Information
Table 97. Sanofi Immuno-Oncology Treatment Product Overview
Table 98. Sanofi Immuno-Oncology Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Sanofi Business Overview
Table 100. Sanofi Recent Developments
Table 101. Spectrum Pharmaceuticals Immuno-Oncology Treatment Basic Information
Table 102. Spectrum Pharmaceuticals Immuno-Oncology Treatment Product Overview
Table 103. Spectrum Pharmaceuticals Immuno-Oncology Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Spectrum Pharmaceuticals Business Overview
Table 105. Spectrum Pharmaceuticals Recent Developments
Table 106. Takeda Immuno-Oncology Treatment Basic Information
Table 107. Takeda Immuno-Oncology Treatment Product Overview
Table 108. Takeda Immuno-Oncology Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Takeda Business Overview
Table 110. Takeda Recent Developments
Table 111. Global Immuno-Oncology Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Immuno-Oncology Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Immuno-Oncology Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Immuno-Oncology Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Immuno-Oncology Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Immuno-Oncology Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Immuno-Oncology Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Immuno-Oncology Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Immuno-Oncology Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Immuno-Oncology Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Immuno-Oncology Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Immuno-Oncology Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Immuno-Oncology Treatment Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Immuno-Oncology Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Immuno-Oncology Treatment Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Immuno-Oncology Treatment Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Immuno-Oncology Treatment Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Immuno-Oncology Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Immuno-Oncology Treatment Market Size (M USD), 2019-2030
Figure 5. Global Immuno-Oncology Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Immuno-Oncology Treatment Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Immuno-Oncology Treatment Market Size by Country (M USD)
Figure 11. Immuno-Oncology Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Immuno-Oncology Treatment Revenue Share by Manufacturers in 2023
Figure 13. Immuno-Oncology Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Immuno-Oncology Treatment Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Immuno-Oncology Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Immuno-Oncology Treatment Market Share by Type
Figure 18. Sales Market Share of Immuno-Oncology Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Immuno-Oncology Treatment by Type in 2023
Figure 20. Market Size Share of Immuno-Oncology Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Immuno-Oncology Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Immuno-Oncology Treatment Market Share by Application
Figure 24. Global Immuno-Oncology Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Immuno-Oncology Treatment Sales Market Share by Application in 2023
Figure 26. Global Immuno-Oncology Treatment Market Share by Application (2019-2024)
Figure 27. Global Immuno-Oncology Treatment Market Share by Application in 2023
Figure 28. Global Immuno-Oncology Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Immuno-Oncology Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Immuno-Oncology Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Immuno-Oncology Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Immuno-Oncology Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Immuno-Oncology Treatment Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Immuno-Oncology Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Immuno-Oncology Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Immuno-Oncology Treatment Sales Market Share by Country in 2023
Figure 37. Germany Immuno-Oncology Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Immuno-Oncology Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Immuno-Oncology Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Immuno-Oncology Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Immuno-Oncology Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Immuno-Oncology Treatment Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Immuno-Oncology Treatment Sales Market Share by Region in 2023
Figure 44. China Immuno-Oncology Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Immuno-Oncology Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Immuno-Oncology Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Immuno-Oncology Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Immuno-Oncology Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Immuno-Oncology Treatment Sales and Growth Rate (K Units)
Figure 50. South America Immuno-Oncology Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Immuno-Oncology Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Immuno-Oncology Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Immuno-Oncology Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Immuno-Oncology Treatment Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Immuno-Oncology Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Immuno-Oncology Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Immuno-Oncology Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Immuno-Oncology Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Immuno-Oncology Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Immuno-Oncology Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Immuno-Oncology Treatment Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Immuno-Oncology Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Immuno-Oncology Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Immuno-Oncology Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Immuno-Oncology Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Immuno-Oncology Treatment Market Share Forecast by Application (2025-2030)
